Telaprevir- and Boceprevir-Based Triple Therapy for Hepatitis C in Liver Transplant Recipients with Advanced Recurrent Disease: A Multicenter Study

BACKGROUND: Antiviral treatment with sustained virologic response (SVR) improves survival in liver transplant (LT) recipients, and is especially relevant to patients with advanced recurrent hepatitis C virus (HCV). We assessed the safety and efficacy of protease inhibitor (PI)-based triple therapy i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplantation
Main Authors: Verna, Elizabeth C., Saxena, Varun, Burton, James R., O’Leary, Jacqueline G., Dodge, Jennifer L., Stravitz, Richard T., Levitsky, Joshua, Trotter, James F., Everson, Gregory T., Brown, Robert S., Terrault, Norah A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4818984/
https://ncbi.nlm.nih.gov/pubmed/25715116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000000629
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados